Guerbet SA - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring peer group for Guerbet SA are displayed below. This report of Guerbet SA leverages data points from across the internet and also from public documents by Guerbet SA. Check the end of the page for potential risks for Guerbet SA based on sector, location and size.
Guerbet SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.4; made up of an environmental score of 8.0, social score of 6.4 and governance score of 4.8.
6.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
| 401 | Oxford Cannabinoid Technologies Holdings PLC | 6.5 | High |
| 402 | Guerbet SA | 6.4 | High |
| 402 | Capricor Therapeutics Inc | 6.4 | High |
| 402 | Alembic Pharmaceuticals Ltd | 6.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Guerbet SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Guerbet SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Guerbet SA report the average age of the workforce?
Sign up for free to unlockDoes Guerbet SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Guerbet SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Guerbet SA disclose cybersecurity risks?
Sign up for free to unlockDoes Guerbet SA offer flexible work?
Sign up for free to unlockDoes Guerbet SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Guerbet SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Guerbet SA conduct supply chain audits?
Sign up for free to unlockDoes Guerbet SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Guerbet SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Guerbet SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Guerbet SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Guerbet SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Guerbet SA disclose water use targets?
Sign up for free to unlockDoes Guerbet SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Guerbet SA have a product recall in the last two years?
Sign up for free to unlockDoes Guerbet SA disclose incidents of discrimination?
Sign up for free to unlockDoes Guerbet SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Guerbet SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Guerbet SA disclose parental leave metrics?
Sign up for free to unlockDoes Guerbet SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Guerbet SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Guerbet SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Guerbet SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Guerbet SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Guerbet SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Guerbet SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Guerbet SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Guerbet SA disclose its waste policy?
Sign up for free to unlockDoes Guerbet SA report according to TCFD requirements?
Sign up for free to unlockDoes Guerbet SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Guerbet SA disclose energy use targets?
Sign up for free to unlockDoes Guerbet SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Guerbet SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Guerbet SA
These potential risks are based on the size, segment and geographies of the company.
Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodinated agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; Hexabrix, an ionic low osmolar contrast medium agent; and Micropaque/ Microtrast, a diagnostic imaging interconnected solution. The company's products for the magnetic resonance imaging examinations comprise Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; Patent Blue V, an injectable medium; and SeQure and DraKon, a microcatheters. Further, the company offers delivery systems and services comprising injectors; consumables for various types of injectors; Contrast&Care, a patient data management software; Dose&Care, an operational solution for monitoring patient exposure to ionizing radiation; and Hydra Vision, a digital imaging system for urological, gastroenterological, gynecological treatment, and planning and diagnostic procedures. The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France.